|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
0.11/-0.12
|
企業價值
96.28M
|
資產負債 |
每股賬面淨值
3.88
|
現金流量 |
現金流量率
--
|
損益表 |
收益
--
|
每股收益
0.07
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
報價延遲最少15分鐘:2025/01/12 03:29 EST
同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901. |